ASCO
Jun 08, 2017
AZ offloads; Pfizer’s deal; Takeda’s work on plant; Germany’s doc payment
AstraZeneca offloads headache drug Zomig to Grünenthal to raise $300M cash AstraZeneca had some positive news to announce at ASCO about its PARP Lynparza for treating breast cancer, but all in all, the U.K. company continues to struggle and so will sell yet another asset to raise cash while CEO Pascal Soriot works t...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
